145 related articles for article (PubMed ID: 12475900)
21. Human CD55 expression blocks hyperacute rejection and restricts complement activation in Gal knockout cardiac xenografts.
McGregor CG; Ricci D; Miyagi N; Stalboerger PG; Du Z; Oehler EA; Tazelaar HD; Byrne GW
Transplantation; 2012 Apr; 93(7):686-92. PubMed ID: 22391577
[TBL] [Abstract][Full Text] [Related]
22. Expression of human alpha-galactosidase and alpha1,2-fucosyltransferase genes modifies the cell surface Galalpha1,3Gal antigen and confers resistance to human serum-mediated cytolysis.
Jia Y; Ren H; Gao X; Ji S; Yang J; Liu Z; Li S; Zhang Y
Chin Med Sci J; 2004 Mar; 19(1):31-7. PubMed ID: 15104222
[TBL] [Abstract][Full Text] [Related]
23. Enzymatic remodelling of the carbohydrate surface of a xenogenic cell substantially reduces human antibody binding and complement-mediated cytolysis.
Sandrin MS; Fodor WL; Mouhtouris E; Osman N; Cohney S; Rollins SA; Guilmette ER; Setter E; Squinto SP; McKenzie IF
Nat Med; 1995 Dec; 1(12):1261-7. PubMed ID: 7489406
[TBL] [Abstract][Full Text] [Related]
24. Fucosyl transferase (H) transgenic heart transplants to Gal-/- mice.
McKenzie IF; Li YQ; Patton K; Sandrin MS
Transplantation; 2000 Oct; 70(8):1205-9. PubMed ID: 11063342
[TBL] [Abstract][Full Text] [Related]
25. Gal alpha (1,3)Gal, the major xenoantigen(s) recognised in pigs by human natural antibodies.
Sandrin MS; McKenzie IF
Immunol Rev; 1994 Oct; 141():169-90. PubMed ID: 7532618
[TBL] [Abstract][Full Text] [Related]
26. Naturally acquired anti-alpha Gal antibodies in a murine allograft model similar to delayed xenograft rejection.
Salvaris E; Gock H; Han W; Murray-Segal L; Barlow H; Mottram P; Pearse M; Cowan P; Goodman D; d'Apice AJ
Xenotransplantation; 2000 Feb; 7(1):42-7. PubMed ID: 10809056
[TBL] [Abstract][Full Text] [Related]
27. Tolerization of anti-Galalpha1-3Gal natural antibody-forming B cells by induction of mixed chimerism.
Yang YG; deGoma E; Ohdan H; Bracy JL; Xu Y; Iacomini J; Thall AD; Sykes M
J Exp Med; 1998 Apr; 187(8):1335-42. PubMed ID: 9547344
[TBL] [Abstract][Full Text] [Related]
28. Histopathology of xenografts in pig to non-human primate discordant xenotransplantation.
Shimizu A; Yamada K
Clin Transplant; 2010 Jul; 24 Suppl 22():11-5. PubMed ID: 20590687
[TBL] [Abstract][Full Text] [Related]
29. Mechanism of delayed rejection in transgenic pig-to-primate cardiac xenotransplantation.
Chen RH; Kadner A; Mitchell RN; Adams DH
J Surg Res; 2000 May; 90(2):119-25. PubMed ID: 10792951
[TBL] [Abstract][Full Text] [Related]
30. Transgenic pigs designed to express human CD59 and H-transferase to avoid humoral xenograft rejection.
Costa C; Zhao L; Burton WV; Rosas C; Bondioli KR; Williams BL; Hoagland TA; Dalmasso AP; Fodor WL
Xenotransplantation; 2002 Jan; 9(1):45-57. PubMed ID: 12005104
[TBL] [Abstract][Full Text] [Related]
31. Porcine and bovine cartilage transplants in cynomolgus monkey: II. Changes in anti-Gal response during chronic rejection.
Galili U; LaTemple DC; Walgenbach AW; Stone KR
Transplantation; 1997 Mar; 63(5):646-51. PubMed ID: 9075832
[TBL] [Abstract][Full Text] [Related]
32. Rejection of cardiac xenografts transplanted from alpha1,3-galactosyltransferase gene-knockout (GalT-KO) pigs to baboons.
Hisashi Y; Yamada K; Kuwaki K; Tseng YL; Dor FJ; Houser SL; Robson SC; Schuurman HJ; Cooper DK; Sachs DH; Colvin RB; Shimizu A
Am J Transplant; 2008 Dec; 8(12):2516-26. PubMed ID: 19032222
[TBL] [Abstract][Full Text] [Related]
33. Characteristics of α-Gal epitope, anti-Gal antibody, α1,3 galactosyltransferase and its clinical exploitation (Review).
Huai G; Qi P; Yang H; Wang Y
Int J Mol Med; 2016 Jan; 37(1):11-20. PubMed ID: 26531137
[TBL] [Abstract][Full Text] [Related]
34. Xenoantibody response to porcine islet cell transplantation using GTKO, CD55, CD59, and fucosyltransferase multiple transgenic donors.
Chen Y; Stewart JM; Gunthart M; Hawthorne WJ; Salvaris EJ; O'Connell PJ; Nottle MB; d'Apice AJ; Cowan PJ; Kearns-Jonker M
Xenotransplantation; 2014; 21(3):244-53. PubMed ID: 24645827
[TBL] [Abstract][Full Text] [Related]
35. Transgenic mice designed to express human alpha-1,2-fucosyltransferase in combination of human DAF and CD59 to avoid xenograft rejection.
Liu B; Cheng C; Wu Y; Wei J; Li G; Ma T
Sci China C Life Sci; 2008 Mar; 51(3):199-204. PubMed ID: 18246307
[TBL] [Abstract][Full Text] [Related]
36. Comparative analysis of three genetic modifications designed to inhibit human serum-mediated cytolysis.
Costa C; Zhao L; Decesare S; Fodor WL
Xenotransplantation; 1999 Feb; 6(1):6-16. PubMed ID: 10355728
[TBL] [Abstract][Full Text] [Related]
37. Porcine and bovine cartilage transplants in cynomolgus monkey: I. A model for chronic xenograft rejection.
Stone KR; Walgenbach AW; Abrams JT; Nelson J; Gillett N; Galili U
Transplantation; 1997 Mar; 63(5):640-5. PubMed ID: 9075831
[TBL] [Abstract][Full Text] [Related]
38. Characterization of Mono- and Bi-Transgenic Pig-Derived Epidermal Keratinocytes Expressing Human
Wiater J; Samiec M; Wartalski K; Smorąg Z; Jura J; Słomski R; Skrzyszowska M; Romek M
Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34575846
[TBL] [Abstract][Full Text] [Related]
39. Double transgenic pigs with combined expression of human α1,2-fucosyltransferase and α-galactosidase designed to avoid hyperacute xenograft rejection.
Zeyland J; Woźniak A; Gawrońska B; Juzwa W; Jura J; Nowak A; Słomski R; Smorąg Z; Szalata M; Mazurek U; Lipiński D
Arch Immunol Ther Exp (Warsz); 2014 Oct; 62(5):411-22. PubMed ID: 24554032
[TBL] [Abstract][Full Text] [Related]
40. A murine model of antibody-mediated hyperacute rejection by galactose-alpha(1,3)galactose antibodies in Gal o/o mice.
McKenzie IF; Li YQ; Patton K; Thall AD; Sandrin MS
Transplantation; 1998 Sep; 66(6):754-63. PubMed ID: 9771839
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
